Quantitative determination of vapor-phase compound A in sevoflurane anesthesia using gas chromatography-mass spectrometry

Clinical Chemistry

Volumn 47, Issue 2, 2001, Pages 281-291

  Bouche, M P L A ^a   Van Bocxlaer, J F P ^a   Rolly, G ^a   Versichelen, L F M ^a   Struys, M M R F ^a   Mortier, E ^a   De Leenheer, A P ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1 TRIFLUORO 2 IODOETHANE; ACETIC ACID ETHYL ESTER; ALKANE DERIVATIVE; ALKENE DERIVATIVE; DRUG METABOLITE; FLUOROMETHYL 1,1,3,3,3 PENTAFLUORO 2 PROPENYL ETHER; SEVOFLURANE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DETERMINATION; GAS CHROMATOGRAPHY; INHALATION ANESTHESIA; MASS SPECTROMETRY; QUANTITATIVE ASSAY; RELIABILITY; VAPOR;

TRIFLUORO;

EID: 0035133201     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.2.281     Document Type: Article

References (33)

1. Sevoflurane: A new inhalational anesthetic agent
2. Sevoflurane - A long-awaited volatile anaesthetic
3. Clinical pharmacokinetics of sevoflurane
4. A comparative review of the newer inhalational anaesthetics
5. Biotransformation of sevoflurane
6. Fluoride ion toxicity in human kidney collecting duct cells
7. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers
8. Stability of sevoflurane in soda lime
9. Decomposition of sevoflurane by sodalime
10. Closed-circuit anesthesia with sevoflurane in humans
11. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in sodalime temperature
12. 2 absorbants during low-flow anesthesia in surgical patients
13. Sevoflurane degradation to compound A in anaesthesia breathing systems
14. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents
15. Factors affecting the rate of disappearance of sevoflurane in Baralyme
16. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia
17. Dry soda lime markedly degrades sevoflurane during simulated inhalation induction
18. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme® soda lime
19. Sevoflurane degradation product concentrations with soda lime during prolonged anesthesia
20. Reaction of sevoflurane its degradation products with soda lime. Toxicity of the by-products
21. Toxicity of compound A in rats. Effect of a 3-hour administration
22. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats
23. Low-flow (1 L/min) sevoflurane. Is it safe?
24. Low flow minimal flow with sevoflurane
25. Low-flow anaesthesia
26. Mass-spectrometric evaluation of some recently introduced low flow, closed circuit systems
27. Analysis of sevoflurane degradation products in vapor phase samples
28. A practical guide to analytical method validation
29. Sevoflurane degradation by soda lime in a circle breathing system
30. All closed anesthesia circuits are not identical for compound A formation during in-vitro sevoflurane
31. In vitro analysis of compound A formation by sevoflurane in a computer controlled closed circuit Physioflex® anesthesia apparatus
32. 2 absorbents